Recent Posts

RT @ThomasCiullaMD: Honored to have been interviewed on Gene Therapy, by America…

[ad_1] RT @ThomasCiullaMD: Honored to have been interviewed on Gene Therapy, by American Society of Retina Specialist’s @asrsdocs Tim Murray….… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

Honored to have been interviewed on Gene Therapy, by American Society of Retina …

[ad_1] Honored to have been interviewed on Gene Therapy, by American Society of Retina Specialist’s @asrsdocs Tim Murray…. #eyes #Ophthalmology #retina #genetherapy https://t.co/cIXkE5ZbMI [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

Thank you so much Drs. Nguyen and Do for your kind invitation to participate in …

[ad_1]

Thank you so much Drs. Nguyen and Do for your kind invitation to participate in 2020 Sonoma Eye – Third Session on January 30 2020! Please join us at https://t.co/GAdGJ5Y1Br https://t.co/mGrUaE5t8j
[ad_2]

Source by Thomas Ciulla, MD, MBA

Return to main website.

Just published: Even in common disorders such as diabetic macular edema, macular…

[ad_1] Just published: Even in common disorders such as diabetic macular edema, macular anatomy, often used for treatment decisions & clinical trial endpoints, has limited correlation to visual acuity. #eyes #retina #diabetes #clinicalresearch #biotech #medicine https://t.co/mVTtQ4N1N1 [ad_2] Source by Thomas Ciulla, MD, MBA Return to 

RT @ThomasCiullaMD: Just published: Precision medicine is predicated on genetic…

[ad_1] RT @ThomasCiullaMD: Just published: Precision medicine is predicated on genetic testing. However, barriers of cost, complexity, and unfam… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

Just published: Precision medicine is predicated on genetic testing. However, …

[ad_1]
Just published: Precision medicine is predicated on genetic testing. However, barriers of cost, complexity, and unfamiliarity with genetic testing illustrate unmet need. Educational efforts are underway.
#eyes #retina #gene #genetics #genetherapy
https://t.co/IAI8Lh5bi7
[ad_2]

Source by Thomas Ciulla, MD, MBA

Return to main website.

RT @ThomasCiullaMD: Just co-authored this paper on integrin inhibition, a potent…

[ad_1] RT @ThomasCiullaMD: Just co-authored this paper on integrin inhibition, a potentially important pathway for treatment of common causes of v… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

RT @PharmacDaily: Clearside Biomedical Announces First Patients Enrolled in Phas…

[ad_1] RT @PharmacDaily: Clearside Biomedical Announces First Patients Enrolled in Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspen… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ThomasCiullaMD: Just published-With clinical trials from small molecules to …

[ad_1]
RT @ThomasCiullaMD: Just published-With clinical trials from small molecules to #genetherapy to viral nanoparticles, for disorders from #ma…
[ad_2]

Source by Thomas Ciulla, MD, MBA

Return to main website.

RT @ThomasCiullaMD: I have great fun & satisfaction mentoring @IU_Health reside…

[ad_1] RT @ThomasCiullaMD: I have great fun & satisfaction mentoring @IU_Health residents interested in #research. Congrats to this fantastic IU… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.